- Ha JT, Badve SV, Jun M. Recent evidence for direct oral anticoagulants in chronic kidney disease. Curr Opin Nephrol Hypertens. 2019 May;28(3):251-261. [PubMed]
- Ha JT, Neuen BL, Cheng LP, Jun M, Toyama T, Gallagher MP, Jardine MJ, Sood MM, Garg AX, Palmer SC, Mark PB, Wheeler DC, Jha V, Freedman B, Johnson DW, Perkovic V, Badve SV. Benefits and Harms of Oral Anticoagulant Therapy in Chronic Kidney Disease: A Systematic Review and Meta-analysis. Ann Intern Med. 2019;171(3): 181-189. [PubMed]
- Ashley J, McArthur E, Bota S, Harel Z, Battistella M, Molnar AO, Jun M, Badve SV, Garg AX, Manuel D, Tanuseputro P, Wells P, Mavrakanas T, Rhodes E, Sood MM. Risk of Cardiovascular Events and Mortality Among Elderly Patients With Reduced GFR Receiving Direct Oral Anticoagulants. Am J Kidney Dis. 2020 Apr 22. doi: 10.1053/j.ajkd.2020.02.446. [PubMed]
- Laurent Billot, Muh Geot Wong, An De Vriese, David Collister, Adrien Flahault, Lily Mushahar, Raja Ramachandran, Habib Skhiri, Ahmed Shaman, Jan Menne, Martin Gallagher. Statistical Analysis Plan for the Treatment of Cardiovascular disease with low dose Rivaroxaban in Advanced CKD (TRACK) trial. MedRxiv. November 27, 2025. doi: https://doi.org/10.1101/2025.11.25.25340065. [MedRxiv]
